Clinical effectiveness and cost-effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial
Author(s) -
Julie Brittenden,
Seonaidh Cotton,
Andrew Elders,
Emma Tassie,
Graham Scotland,
Craig Ramsay,
John Norrie,
Jennifer Burr,
Jill Francis,
Samantha Wileman,
Bruce Campbell,
Paul Bachoo,
Ian Chetter,
Michael J. Gough,
J J Earnshaw,
Tim Lees,
Julian Scott,
Sara A Baker,
Graeme MacLennan,
Maria Prior,
Denise Bolsover,
Marion Campbell
Publication year - 2015
Publication title -
health technology assessment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.426
H-Index - 126
eISSN - 2046-4924
pISSN - 1366-5278
DOI - 10.3310/hta19270
Subject(s) - varicose veins , medicine , sclerotherapy , surgery , randomized controlled trial , confidence interval , quality of life (healthcare) , blinding , cost effectiveness , randomization , nursing , risk analysis (engineering)
Foam sclerotherapy (foam) and endovenous laser ablation (EVLA) have emerged as alternative treatments to surgery for patients with varicose veins, but uncertainty exists regarding their effectiveness in the medium to longer term.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom